Genertec Universal Medical Group Company Limited

SEHK:2666 주식 보고서

시가총액: HK$8.0b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Genertec Universal Medical Group 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Wang Wenbing

최고 경영자

CN¥4.5m

총 보상

CEO 급여 비율32.2%
CEO 임기7.4yrs
CEO 소유권n/a
경영진 평균 재임 기간1.3yrs
이사회 평균 재임 기간2.1yrs

최근 관리 업데이트

Recent updates

Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

May 22
Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Genertec Universal Medical Group Company Limited's (HKG:2666) Price Is Right But Growth Is Lacking

May 10
Genertec Universal Medical Group Company Limited's (HKG:2666) Price Is Right But Growth Is Lacking

Why Investors Shouldn't Be Surprised By Genertec Universal Medical Group Company Limited's (HKG:2666) Low P/E

Feb 05
Why Investors Shouldn't Be Surprised By Genertec Universal Medical Group Company Limited's (HKG:2666) Low P/E

Genertec Universal Medical Group (HKG:2666) Is Reducing Its Dividend To CN¥0.34

Jun 08
Genertec Universal Medical Group (HKG:2666) Is Reducing Its Dividend To CN¥0.34

Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Jun 08
Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 31
Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Should You Be Adding Genertec Universal Medical Group (HKG:2666) To Your Watchlist Today?

Aug 20
Should You Be Adding Genertec Universal Medical Group (HKG:2666) To Your Watchlist Today?

Here's Why We Think Genertec Universal Medical Group (HKG:2666) Is Well Worth Watching

Apr 19
Here's Why We Think Genertec Universal Medical Group (HKG:2666) Is Well Worth Watching

Shareholders Of Genertec Universal Medical Group (HKG:2666) Must Be Happy With Their 34% Return

Mar 10
Shareholders Of Genertec Universal Medical Group (HKG:2666) Must Be Happy With Their 34% Return

Is Genertec Universal Medical Group Company Limited (HKG:2666) Trading At A 48% Discount?

Feb 19
Is Genertec Universal Medical Group Company Limited (HKG:2666) Trading At A 48% Discount?

Did Genertec Universal Medical Group Company Limited (HKG:2666) Insiders Buy Up More Shares?

Feb 01
Did Genertec Universal Medical Group Company Limited (HKG:2666) Insiders Buy Up More Shares?

The Case For Genertec Universal Medical Group Company Limited (HKG:2666): Could It Be A Nice Addition To Your Dividend Portfolio?

Jan 11
The Case For Genertec Universal Medical Group Company Limited (HKG:2666): Could It Be A Nice Addition To Your Dividend Portfolio?

What Kind Of Investors Own Most Of Genertec Universal Medical Group Company Limited (HKG:2666)?

Dec 21
What Kind Of Investors Own Most Of Genertec Universal Medical Group Company Limited (HKG:2666)?

Reflecting on Genertec Universal Medical Group's (HKG:2666) Share Price Returns Over The Last Three Years

Nov 30
Reflecting on Genertec Universal Medical Group's (HKG:2666) Share Price Returns Over The Last Three Years

CEO 보상 분석

Wang Wenbing 의 보수는 Genertec Universal Medical Group 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Dec 31 2023CN¥4mCN¥1m

CN¥2b

Sep 30 2023n/an/a

CN¥2b

Jun 30 2023n/an/a

CN¥2b

Mar 31 2023n/an/a

CN¥2b

Dec 31 2022CN¥4mCN¥1m

CN¥2b

Sep 30 2022n/an/a

CN¥2b

Jun 30 2022n/an/a

CN¥2b

Mar 31 2022n/an/a

CN¥2b

Dec 31 2021CN¥2mCN¥731k

CN¥2b

보상 대 시장: Wang 의 총 보상 ($USD 618.32K )은 Hong Kong 시장( $USD 450.61K ).

보상과 수익: Wang 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

Wang Wenbing (50 yo)

7.4yrs

테뉴어

CN¥4,489,000

보상

Mr. Wang Wenbing is General Manager of China Universal Leasing Co., Ltd since October 14, 2021. He has been Deputy General Manager of Genertec Universal Medical Group Company Limited (formerly known as Uni...


리더십 팀

이름위치테뉴어보상소유권
Wang Wenbing
CEO & Executive Director7.4yrsCN¥4.49m데이터 없음
Lin Wang
Executive Directorless than a yearCN¥965.00k데이터 없음
Shisu Chen
Executive Chairmanless than a year데이터 없음데이터 없음
Shinan Wang
Chief Accounting Officer & General Counsel1.3yrs데이터 없음데이터 없음
Feng Qingming
Chief Medical Officerno data데이터 없음데이터 없음
Wai Kam Ng
Company Secretary4.6yrs데이터 없음데이터 없음

1.3yrs

평균 재임 기간

50yo

평균 연령

경험이 풍부한 관리: 2666 의 관리팀은 경험 (평균 재직 기간 1.2 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
Wang Wenbing
CEO & Executive Director2.8yrsCN¥4.49m데이터 없음
Lin Wang
Executive Directorless than a yearCN¥965.00k데이터 없음
Shisu Chen
Executive Chairmanless than a year데이터 없음데이터 없음
Yinquan Li
Independent Non-Executive Director9.1yrsCN¥363.00k데이터 없음
Zhiming Xu
Independent Non-executive Director2.1yrsCN¥363.00k데이터 없음
Kai Kong Chan
Non-Executive Vice-Chairman2.1yrs데이터 없음0.0016%
CN¥ 127.8k
Siu Lui Chow
Independent Non-Executive Director9.1yrsCN¥363.00k데이터 없음
Ming Xu
Non-Executive Director2.1yrs데이터 없음데이터 없음
Chaoyin Tong
Non-Executive Director3.2yrs데이터 없음데이터 없음
Hiu Fung Chan
Independent Non-executive Director2.1yrsCN¥363.00k데이터 없음
Ziyang Zhu
Non-Executive Director3yrs데이터 없음데이터 없음

2.1yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 이사회: 2666 의 이사회경험(평균 재직 기간 2 년)으로 간주되지 않으므로 새 이사회가 필요합니다.